Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

XTRA:UZU
XTRA:UZUChemicals

Unearthing European Hidden Gems with Promising Potential

As the eurozone economy continues its modest recovery with stronger investment and consumer confidence, European markets are showing resilience despite mixed performances among major stock indexes. In this environment, identifying hidden gems within the small-cap sector can be particularly rewarding, as these stocks often offer unique growth opportunities that align well with improving economic sentiment and expanding household consumption.
XTRA:DWS
XTRA:DWSCapital Markets

Top European Dividend Stocks To Watch In February 2026

As the eurozone economy continues its modest recovery, bolstered by stronger investment and household consumption, European markets have shown resilience despite ongoing geopolitical uncertainties. With the pan-European STOXX Europe 600 Index recently ending higher on earnings optimism, investors are increasingly drawn to dividend stocks for their potential to provide steady income in a fluctuating market environment.
NYSE:AA
NYSE:AAMetals and Mining

Assessing Alcoa (AA) Valuation After Aluminum Price Rally And Stronger Production Guidance

Alcoa (AA) is back in focus after a sharp rally in aluminum prices, along with fresh 2025 production guidance and full-year 2025 results that highlighted higher sales and earnings from continuing operations. See our latest analysis for Alcoa. Those stronger 2025 results and higher production guidance have arrived at the same time as a powerful swing in sentiment toward aluminum, with Alcoa’s share price up 65.09% over the past 90 days and a 1 year total shareholder return of 72.84%,...
NasdaqGS:MTCH
NasdaqGS:MTCHInteractive Media and Services

A Look At Match Group (MTCH) Valuation As Returns Lag Revenue And Income Growth

How Match Group’s Recent Returns Compare With Its Fundamentals Match Group (MTCH) has delivered a 1 day return of 1.25%, while the past week, month, and past 3 months have each been slightly negative, and the 1 year and 3 year total returns remain under pressure. Against that backdrop, the company reports annual revenue of US$3.47b and net income of US$562.09m, with both revenue and net income showing annual growth. This provides a clearer context for assessing the share price...
CPSE:DANSKE
CPSE:DANSKEBanks

Is Danske Bank’s DKK 5 Billion Buyback And Share Cancellation Altering The Investment Case For Danske Bank (CPSE:DANSKE)?

Danske Bank has completed its DKK 5,000,000,000 share buy-back programme, repurchasing 19,179,623 shares that are expected to be cancelled subject to shareholder approval at the March 26, 2026 annual general meeting. This move underscores a capital position that allows meaningful cash returns to investors and signals management’s confidence in the bank’s current trajectory. We’ll now examine how the completed DKK 5,000,000,000 buy-back and planned share cancellation shape Danske Bank’s...
NYSE:DCI
NYSE:DCIMachinery

Donaldson Weighs CEO Shift And Facet Deal As Valuation Premium Looms

Donaldson Company (NYSE:DCI) has announced a CEO transition, with current COO Richard Lewis set to succeed retiring CEO Tod Carpenter. The company has also entered into a definitive agreement to acquire Filtration Group's Facet Filtration business. Facet Filtration adds fuel and fluid filtration capabilities with exposure to aerospace, defense, and power generation markets. For investors watching NYSE:DCI, these updates come as the stock trades around $101.17, with a 1 year return of 47.6%...
ASX:TLX
ASX:TLXBiotechs

Assessing Telix Pharmaceuticals (ASX:TLX) Valuation After Regulatory Setbacks And Rising Investor Caution

Regulatory setbacks put Telix Pharmaceuticals (ASX:TLX) under closer investor scrutiny Telix Pharmaceuticals (ASX:TLX) is back in focus after three FDA rejections and an ongoing SEC investigation. These events have coincided with a sharp share price pullback and heightened regulatory risk. See our latest analysis for Telix Pharmaceuticals. The regulatory setbacks have coincided with a steep reset in sentiment, with a 90 day share price return of a 33.46% decline and a 1 year total shareholder...
ENXTAM:KPN
ENXTAM:KPNTelecom

Does KPN’s (ENXTAM:KPN) 2026 Buyback and Revenue Guidance Recast Its Capital Allocation Priorities?

In late January 2026, Koninklijke KPN N.V. initiated a €250 million share buyback program and issued 2026 guidance targeting 2% to 2.5% service revenue growth. Together, the capital return plan and explicit service revenue outlook offer fresh insight into how KPN’s management is positioning the business for the year ahead. With KPN’s new share buyback underway, we’ll examine how this capital return focus shapes the company’s broader investment narrative. Uncover the next big thing with...
NasdaqGS:AVT
NasdaqGS:AVTElectronic

Why Avnet (AVT) Is Up 23.2% After Completing $886 Million Buyback And Issuing EPS Guidance

In late January 2026, Avnet, Inc. reported fiscal second-quarter 2026 results showing higher sales of US$6,318.96 million but lower net income of US$61.73 million versus the prior year, and issued guidance for third-quarter GAAP diluted EPS between US$0.95 and US$1.15. The company also confirmed it has completed a US$886 million share repurchase program launched in 2022, retiring 18,525,241 shares, which signals a sustained focus on capital returns alongside operational efficiencies and...
NasdaqGS:ADEA
NasdaqGS:ADEASoftware

A Look At Adeia (ADEA) Valuation After Recent Executive Leadership Team Changes

What Adeia’s Leadership Shake-Up Could Mean for Shareholders Adeia (ADEA) has just reshaped its senior ranks, bringing in new leaders for semiconductor R&D, revenue, and corporate planning while planning for a key executive exit. This is a shift investors will likely watch closely. See our latest analysis for Adeia. At a share price of $18.79, Adeia has seen a 47.37% 90 day share price return and a 50.74% 1 year total shareholder return, which indicates recent momentum ahead of these...
NasdaqGS:CVCO
NasdaqGS:CVCOConsumer Durables

Cavco Industries (CVCO) Earnings Growth Outpaces Five Year Trend And Supports Premium P/E Narrative

Cavco Industries (CVCO) opened its Q3 2026 update with revenue of US$581.0 million and basic EPS of US$5.65, alongside trailing twelve month figures of US$2.2 billion in revenue and EPS of US$23.28 that continue to frame the earnings story. The company has seen quarterly revenue move from US$508.4 million in Q4 2025 to the mid US$500 million range in the first half of 2026, while basic EPS has ranged between US$4.53 and US$6.97 over the past six reported quarters, giving investors a clear...
NasdaqGS:OPEN
NasdaqGS:OPENReal Estate

Assessing Opendoor Technologies (OPEN) Valuation After Strong Multi‑Year Shareholder Returns

Why Opendoor Technologies is Back on Watchlists Opendoor Technologies (OPEN) has drawn fresh attention after recent share price moves, with the stock now around $4.82. That puts recent performance, business fundamentals, and risk profile in sharper focus for investors. See our latest analysis for Opendoor Technologies. While the latest 1-day share price return of a 6.41% decline to US$4.82 adds short-term pressure, the 1-year total shareholder return of 265.15% and 3-year total shareholder...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

Viatris (VTRS) Valuation Check As Inpefa UAE Launch Extends Its Cardiovascular Growth Story

How the Inpefa launch ties into the Viatris (VTRS) story Viatris (VTRS) is in focus after launching Inpefa, or sotagliflozin, in the United Arab Emirates, its first commercialization of the heart failure treatment within its territories outside the U.S. and Europe. The move connects directly to the company’s effort to widen access to a dual SGLT1/2 inhibitor in cardiovascular care across additional markets, following its licensing agreement with Lexicon Pharmaceuticals and a series of...
NYSE:MDT
NYSE:MDTMedical Equipment

Does Expanded Medicare Access For MiniMed 780G Reshape The Bull Case For Medtronic (MDT)?

In early February 2026, Medtronic reported three major U.S. milestones for its MiniMed 780G insulin delivery system, including Medicare access when paired with Abbott’s Instinct sensor, FDA clearance to use ultra rapid-acting insulins, and expanded clearance for insulin-requiring type 2 diabetes. By combining automated insulin delivery, longer-wear discreet sensing, and more flexible insulin options, Medtronic is aiming to make intensive diabetes management less burdensome and more tailored...
NYSE:XPEV
NYSE:XPEVAuto

Why XPeng (XPEV) Is Down 12.2% After Global P7+ Launch And January Delivery Update

XPeng Inc. reported that it delivered 20,011 vehicles in January 2026 and launched its P7+ model globally, including a European debut at the Brussels Motor Show. The company linked these deliveries to a sizeable reduction in life-cycle greenhouse gas emissions and highlighted its push into advanced AI, in-house chip development, and next-generation mobility as it expands beyond its home market. We’ll now examine how XPeng’s global P7+ launch and technology push might influence the company’s...